Form 8-K - Current report:
SEC Accession No. 0001558370-24-015838
Filing Date
2024-11-18
Accepted
2024-11-18 08:15:30
Documents
59
Period of Report
2024-11-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20241116x8k.htm   iXBRL 8-K 80873
2 EX-10.1 acrs-20241116xex10d1.htm EX-10.1 268666
3 EX-10.2 acrs-20241116xex10d2.htm EX-10.2 123160
4 EX-10.3 acrs-20241116xex10d3.htm EX-10.3 117280
5 EX-10.4 acrs-20241116xex10d4.htm EX-10.4 165473
6 EX-10.5 acrs-20241116xex10d5.htm EX-10.5 95178
7 EX-10.6 acrs-20241116xex10d6.htm EX-10.6 71088
8 EX-99.1 acrs-20241116xex99d1.htm EX-99.1 19179
9 EX-99.2 acrs-20241116xex99d2.htm EX-99.2 9748
10 EX-99.3 acrs-20241116xex99d3.htm EX-99.3 62374
11 GRAPHIC acrs-20241116xex99d1001.jpg GRAPHIC 7580
12 GRAPHIC acrs-20241116xex99d2001.jpg GRAPHIC 12837
13 GRAPHIC acrs-20241116xex99d3g001.jpg GRAPHIC 131595
14 GRAPHIC acrs-20241116xex99d3g002.jpg GRAPHIC 367872
15 GRAPHIC acrs-20241116xex99d3g003.jpg GRAPHIC 170663
16 GRAPHIC acrs-20241116xex99d3g004.jpg GRAPHIC 139459
17 GRAPHIC acrs-20241116xex99d3g005.jpg GRAPHIC 154571
18 GRAPHIC acrs-20241116xex99d3g006.jpg GRAPHIC 124366
19 GRAPHIC acrs-20241116xex99d3g007.jpg GRAPHIC 155250
20 GRAPHIC acrs-20241116xex99d3g008.jpg GRAPHIC 191526
21 GRAPHIC acrs-20241116xex99d3g009.jpg GRAPHIC 152577
22 GRAPHIC acrs-20241116xex99d3g010.jpg GRAPHIC 144850
23 GRAPHIC acrs-20241116xex99d3g011.jpg GRAPHIC 164082
24 GRAPHIC acrs-20241116xex99d3g012.jpg GRAPHIC 175549
25 GRAPHIC acrs-20241116xex99d3g013.jpg GRAPHIC 157176
26 GRAPHIC acrs-20241116xex99d3g014.jpg GRAPHIC 136288
27 GRAPHIC acrs-20241116xex99d3g015.jpg GRAPHIC 159970
28 GRAPHIC acrs-20241116xex99d3g016.jpg GRAPHIC 161603
29 GRAPHIC acrs-20241116xex99d3g017.jpg GRAPHIC 172863
30 GRAPHIC acrs-20241116xex99d3g018.jpg GRAPHIC 147680
31 GRAPHIC acrs-20241116xex99d3g019.jpg GRAPHIC 157452
32 GRAPHIC acrs-20241116xex99d3g020.jpg GRAPHIC 119970
33 GRAPHIC acrs-20241116xex99d3g021.jpg GRAPHIC 127831
34 GRAPHIC acrs-20241116xex99d3g022.jpg GRAPHIC 154424
35 GRAPHIC acrs-20241116xex99d3g023.jpg GRAPHIC 244154
36 GRAPHIC acrs-20241116xex99d3g024.jpg GRAPHIC 168053
37 GRAPHIC acrs-20241116xex99d3g025.jpg GRAPHIC 159042
38 GRAPHIC acrs-20241116xex99d3g026.jpg GRAPHIC 155178
39 GRAPHIC acrs-20241116xex99d3g027.jpg GRAPHIC 138982
40 GRAPHIC acrs-20241116xex99d3g028.jpg GRAPHIC 135163
41 GRAPHIC acrs-20241116xex99d3g029.jpg GRAPHIC 186497
42 GRAPHIC acrs-20241116xex99d3g030.jpg GRAPHIC 201274
43 GRAPHIC acrs-20241116xex99d3g031.jpg GRAPHIC 109771
44 GRAPHIC acrs-20241116xex99d3g032.jpg GRAPHIC 206662
45 GRAPHIC acrs-20241116xex99d3g033.jpg GRAPHIC 146962
46 GRAPHIC acrs-20241116xex99d3g034.jpg GRAPHIC 174215
47 GRAPHIC acrs-20241116xex99d3g035.jpg GRAPHIC 140935
  Complete submission text file 0001558370-24-015838.txt   9243409

Data Files

Seq Description Document Type Size
48 EX-101.SCH acrs-20241116.xsd EX-101.SCH 3140
49 EX-101.LAB acrs-20241116_lab.xml EX-101.LAB 15921
50 EX-101.PRE acrs-20241116_pre.xml EX-101.PRE 10228
61 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20241116x8k_htm.xml XML 4888
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 241469806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)